Trial
NCT03794583
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
United Therapeutics
Collaborators
Lung Biotechnology PBC
Condition
Pulmonary Hypertension
Intervention
Inhaled treprostinil solution
Why stopped
Sponsor's decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-27